Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Neurology
|
November 20, 2021
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus
Maria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Neurology
|
March 23, 2024
Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus
Maria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Neurology
|
October 31, 2020
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome
Anne B Tjensvoll, Maria B Lauvsnes, Henrik Zetterberg, et al.
Clinical and Experimental Medicine
|
February 8, 2026
Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway
Marius Stensland, Karina F Bru, Marie Austdal, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Neurology
|
November 20, 2021
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus
Maria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Neurology
|
March 23, 2024
Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus
Maria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Neurology
|
October 31, 2020
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome
Anne B Tjensvoll, Maria B Lauvsnes, Henrik Zetterberg, et al.
Clinical and Experimental Medicine
|
February 8, 2026
Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway
Marius Stensland, Karina F Bru, Marie Austdal, et al.
Page
of 2